Latest News
BC serology study shows low level of community immunity

—
While BC has flattened its COVID-19 curve, there is not sufficient immunity to prevent a second wave.
That’s the evidence gathered from an initial serology study released yesterday by scientists from the BC Centre for Disease Control (BCCDC) and University of British Columbia, with support from LifeLabs and Michael Smith Foundation for Health Research. The study was the first report of its kind released in Canada and can be found on the BCCDC website.
BC has some of the lowest infection rates in North America, but there is still community transmission as evidenced by infection rate in samples tested. Using layers of protection and following foundational rules for safe social interactions is the way forward to prevent a second wave.
Provincial health officer Dr. Bonnie Henry and Health Minister Adrian Dix also announced 21 new cases, including three epi-linked cases, for a total of 3,170 cases in British Columbia. ‘Epi-linked’ means that public health investigations have shown that cases meet the case definition for COVID-19 but may not have been tested for a number of reasons.
There were no new COVID-19 related deaths or healthcare facility outbreaks. In total, two long-term care or assisted-living facilities and one acute-care facility have active outbreaks.
There is one active community outbreak, in addition to several community exposure events, where alerts have been issued.
A summary of the BCCDC serology study showing estimated community COVID-19 infection rates in BC is available here.
To read the full BCCDC serology study, click here.
For the latest medical updates, including case counts, prevention, risks and testing, visit: http://www.bccdc.ca/ or follow @CDCofBC on Twitter.